Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Complex regional pain syndrome

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Exclude limb-threatening alternatives first

Disproportionate limb pain can also signal compartment syndrome, infection, arterial compromise, DVT, unstable fixation or acute nerve injury, each of which requires a different urgent pathway.

Action: Repeat skin, wound, vascular, neurological and compartment assessment, remove constricting casts or dressings when indicated and obtain urgent surgical or vascular review before attributing acute deterioration to CRPS.

Synopsis

Diagnose complex regional pain syndrome clinically without missing dangerous mimics, then restore function through early coordinated rehabilitation, pain treatment and psychologically informed support.

  • CRPS is continuing regional pain disproportionate to the inciting event with sensory, vasomotor, sudomotor or oedema and motor or trophic abnormalities.
  • Use Budapest criteria: continuing disproportionate pain, symptoms in at least three of four categories, signs on examination in at least two categories and no better diagnosis.
  • First-line assessment is clinical examination and exclusion of dangerous mimics; no blood test, MRI or bone scan confirms CRPS.
  • Type I has no confirmed major nerve injury and type II follows nerve injury, but the rehabilitation principles are similar.
  • Refer early to physiotherapy or occupational therapy and pain services when symptoms are persistent, severe, diagnostically uncertain or function is deteriorating.
  • Management combines clear explanation, desensitisation, graded functional use, oedema and range work, laterality or motor imagery where appropriate and psychological strategies for living with pain.
  • For neuropathic pain, amitriptyline may start at 10 to 25 mg orally in the evening and increase by 10 to 25 mg every 3 to 7 days toward 25 to 75 mg daily as tolerated; review function and adverse effects.
  • Pregabalin may start at a total 150 mg daily in two or three divided doses, rise to 300 mg after 3 to 7 days and at most 600 mg after another 7 days, with renal adjustment and a discontinuation plan.

Key red flags

Pain on passive stretch, tense compartments or rapidly escalating analgesic need after injury or casting requires emergency compartment-syndrome assessment.

Fever, wound discharge, spreading erythema, joint effusion or systemic illness raises concern for infection and needs prompt source investigation.

A cool pale pulseless limb, acute motor loss or worsening perfusion needs immediate vascular and orthopaedic assessment.

Scalding pain confined to one named nerve distribution after surgery or trauma may indicate acute nerve injury or entrapment requiring urgent surgical review.

New whole-limb swelling, venous tenderness, chest pain or breathlessness requires DVT or PE assessment rather than a CRPS assumption.

Suicidal thoughts, severe depression, medication dependence or catastrophic functional collapse requires urgent mental-health or specialist pain support alongside physical care.

Investigation priorities

01
First-line Budapest clinical assessmentFirst stepFirst line

Establish the required pain, symptom and observed-sign pattern while testing whether another diagnosis is better.

Management branches

RecognitionConfirm criteria and exclude danger

Regional pain and autonomic or motor change persist beyond the expected injury course.

  1. Repeat wound, joint, fixation, compartment, vascular and named-nerve examination before applying a pain label.
  2. Document Budapest symptoms and observed signs in each of the four categories.
  3. Order only targeted tests for infection, vascular, structural or nerve alternatives.
  4. Explain the working diagnosis and arrange early therapy and pain follow-up without waiting for a confirmatory scan.

Key medicines

Amitriptyline for neuropathic painStart 10 to 25 mg orally in the evening and increase by 10 to 25 mg every 3 to 7 days as tolerated; the usual neuropathic-pain range is 25 to 75 mg daily.Use lower doses in older or cardiovascular patients; review anticholinergic effects, sedation, falls, urinary retention, glaucoma, arrhythmia, overdose risk and interacting serotonergic medicines.
Pregabalin for neuropathic painStart a total 150 mg orally each day in two or three divided doses; increase to 300 mg daily after 3 to 7 days and, if needed, to no more than 600 mg after another 7 days.Adjust for renal impairment and monitor dizziness, somnolence, oedema, respiratory depression with opioids and misuse; agree gradual discontinuation before starting and never stop abruptly.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • RCP Complex Regional Pain Syndrome GuidelineBudapest diagnosis, differentials, referral, therapy, medicines and specialist rehabilitation.
  • NICE CG173 Neuropathic Pain RecommendationsNon-specialist neuropathic-pain medicine selection, review and referral.
  • NHS Complex Regional Pain TreatmentPatient-centred rehabilitation, pain medicine and psychological support.
  • Amitriptyline Ten Milligram SmPCNeuropathic-pain initiation, titration and safety.
  • Pregabalin Milpharm SmPCNeuropathic-pain dosing, renal adjustment and discontinuation safety.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom